1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioembolization Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Transarterial Radioembolization (TARE)
1.2.3 Selective Internal Radiation Therapy (SIRT)
1.3 Market by Application
1.3.1 Global Radioembolization Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Radioembolization Therapy Market Perspective (2017-2028)
2.2 Radioembolization Therapy Growth Trends by Region
2.2.1 Radioembolization Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radioembolization Therapy Historic Market Size by Region (2017-2022)
2.2.3 Radioembolization Therapy Forecasted Market Size by Region (2023-2028)
2.3 Radioembolization Therapy Market Dynamics
2.3.1 Radioembolization Therapy Industry Trends
2.3.2 Radioembolization Therapy Market Drivers
2.3.3 Radioembolization Therapy Market Challenges
2.3.4 Radioembolization Therapy Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Radioembolization Therapy Players by Revenue
3.1.1 Global Top Radioembolization Therapy Players by Revenue (2017-2022)
3.1.2 Global Radioembolization Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Radioembolization Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioembolization Therapy Revenue
3.4 Global Radioembolization Therapy Market Concentration Ratio
3.4.1 Global Radioembolization Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioembolization Therapy Revenue in 2021
3.5 Radioembolization Therapy Key Players Head office and Area Served
3.6 Key Players Radioembolization Therapy Product Solution and Service
3.7 Date of Enter into Radioembolization Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Radioembolization Therapy Breakdown Data by Type
4.1 Global Radioembolization Therapy Historic Market Size by Type (2017-2022)
4.2 Global Radioembolization Therapy Forecasted Market Size by Type (2023-2028) 5 Radioembolization Therapy Breakdown Data by Application
5.1 Global Radioembolization Therapy Historic Market Size by Application (2017-2022)
5.2 Global Radioembolization Therapy Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Radioembolization Therapy Market Size (2017-2028)
6.2 North America Radioembolization Therapy Market Size by Country (2017-2022)
6.3 North America Radioembolization Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Radioembolization Therapy Market Size (2017-2028)
7.2 Europe Radioembolization Therapy Market Size by Country (2017-2022)
7.3 Europe Radioembolization Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Radioembolization Therapy Market Size (2017-2028)
8.2 Asia-Pacific Radioembolization Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Radioembolization Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Radioembolization Therapy Market Size (2017-2028)
9.2 Latin America Radioembolization Therapy Market Size by Country (2017-2022)
9.3 Latin America Radioembolization Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Radioembolization Therapy Market Size (2017-2028)
10.2 Middle East & Africa Radioembolization Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Radioembolization Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Terumo Corporation
11.1.1 Terumo Corporation Company Detail
11.1.2 Terumo Corporation Business Overview
11.1.3 Terumo Corporation Radioembolization Therapy Introduction
11.1.4 Terumo Corporation Revenue in Radioembolization Therapy Business (2017-2022)
11.1.5 Terumo Corporation Recent Development
11.2 Merit Medical Systems Inc.
11.2.1 Merit Medical Systems Inc. Company Detail
11.2.2 Merit Medical Systems Inc. Business Overview
11.2.3 Merit Medical Systems Inc. Radioembolization Therapy Introduction
11.2.4 Merit Medical Systems Inc. Revenue in Radioembolization Therapy Business (2017-2022)
11.2.5 Merit Medical Systems Inc. Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Detail
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Radioembolization Therapy Introduction
11.3.4 Cook Medical Revenue in Radioembolization Therapy Business (2017-2022)
11.3.5 Cook Medical Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Detail
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Radioembolization Therapy Introduction
11.4.4 Boston Scientific Corporation Revenue in Radioembolization Therapy Business (2017-2022)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Medtronic plc
11.5.1 Medtronic plc Company Detail
11.5.2 Medtronic plc Business Overview
11.5.3 Medtronic plc Radioembolization Therapy Introduction
11.5.4 Medtronic plc Revenue in Radioembolization Therapy Business (2017-2022)
11.5.5 Medtronic plc Recent Development
11.6 Stryker Corporation
11.6.1 Stryker Corporation Company Detail
11.6.2 Stryker Corporation Business Overview
11.6.3 Stryker Corporation Radioembolization Therapy Introduction
11.6.4 Stryker Corporation Revenue in Radioembolization Therapy Business (2017-2022)
11.6.5 Stryker Corporation Recent Development
11.7 Depuy Synthes (J&J)
11.7.1 Depuy Synthes (J&J) Company Detail
11.7.2 Depuy Synthes (J&J) Business Overview
11.7.3 Depuy Synthes (J&J) Radioembolization Therapy Introduction
11.7.4 Depuy Synthes (J&J) Revenue in Radioembolization Therapy Business (2017-2022)
11.7.5 Depuy Synthes (J&J) Recent Development
11.8 BTG International Limited
11.8.1 BTG International Limited Company Detail
11.8.2 BTG International Limited Business Overview
11.8.3 BTG International Limited Radioembolization Therapy Introduction
11.8.4 BTG International Limited Revenue in Radioembolization Therapy Business (2017-2022)
11.8.5 BTG International Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
